Evaluation of the Effect of Gemigliptin on Metabolic Endotoxemia and Lipemia Induced by High Fat Diet in Patients With Type 2 Diabetes
Phase of Trial: Phase II
Latest Information Update: 01 Mar 2017
At a glance
- Drugs Gemigliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 10 Jun 2017 Biomarkers information updated
- 20 Apr 2016 Placebo added to treatment table.
- 20 Apr 2016 Status changed from not yet recruiting to completed.